• Skip to primary navigation
  • Skip to main content
  • Skip to footer
ElevateBio

ElevateBio

Powering the creation of cell & gene therapies at a speed the world deserves.

  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Posters & Publications
    • Elevated Insights
  • Careers
  • Locations
  • Contact
  • Search
  • End-to-End Capabilities
    • End-to-End Capabilities Overview
    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Services and Quality
    • Next-Generation Sequencing
    • Apheresis
    • Enabling Services
  • Technology Platforms
    • Technology Platforms Overview
    • Gene Editing
    • Cell Therapy Enabling Technologies
    • RNA, Protein & Vector Engineering
  • Therapeutic Design & Approaches
    • Therapeutic Design & Approaches Overview
    • Ex Vivo Cell & Gene Therapies
    • In Vivo Gene Therapies
  • Partnering
    • Partnering Overview
    • Industry Partnerships
    • Academic Partnerships
  • About
    • About Overview
    • Our Story
    • Our Ecosystem
    • Our Team
    • Culture of Expedition
    • Careers
  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Posters & Publications
    • Elevated Insights
  • Careers
  • Locations
  • Contact
  • End-to-End Capabilities


    End-to-End Capabilities Overview

    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Services and Quality
    • Next-Generation Sequencing
    • Apheresis
    • Enabling Services
  • Technology Platforms


    Technology Platform Overview

    • Gene Editing
    • Cell Therapy Enabling Technologies
    • RNA, Protein & Vector Engineering
  • Therapeutic Design & Approaches


    Therapeutic Design & Approaches Overview

    • Ex Vivo Cell & Gene Therapies
    • In Vivo Gene Therapies
  • Partnering
    • Partnering Overview
    • Industry Partnerships
    • Academic Partnerships
  • About
    • About Overview
    • Our Story
    • Our Ecosystem
    • Our Team
    • Culture of Expedition
    • Careers

Explore
More

  • Apheresis
  • Next-Generation Sequencing
  • cGMP Manufacturing and Automation
  • Process Development
  • Analytical Services and Quality
  • Enabling Services
Home/End-to-End Capabilities/Analytical Services and Quality

Analytical Services and Quality

Ensuring a safe and well-characterized product, right from the start

// End-to-end
   Capabilities

Analyzing Products from End to End

From concept through development, our team characterizes products and process through robust analytical methods. The result is a well-defined product that meets regulatory requirements and is suitable for your clinical development and commercialization needs.

Accelerating Programs with Quality

Our quality control methods and analytics help accelerate your timelines, saving costs.

The business model at ElevateBio is different because it combines so many different aspects. Being able to have science at a research level- ElevateBio has those capabilities. We’ve got cutting edge research going on, we have clients on the manufacturing side, on the process development side, and the analytical development side.

Nate Cyr

Senior Manager, Laboratory & Site Services

Analytical Services and Quality

Potency Assay Development
Platform Assays
Product QC Release Testing
Stability
Quality Assurance and Validation
Potency Assay Development

Potency Assay Development

Cell and gene therapy potency assays are complex and custom development approaches are needed based on unique product profiles and mechanism of actions of each product. Our team of experts has the technical capabilities and in-house expertise for developing phase-appropriate potency strategies for cell and gene therapy drug products and critical components.

We support a wide range of modalities and mechanisms of action, including genetically modified cell therapies, gene editing, and viral and non-viral vectors.

Our phase appropriate approach to potency assay development includes pre-clinical to first in human, to supporting later stages of development towards commercial filing.

Platform Assays

Platform Assays

Along with our established cell therapy and viral vector platform processes, we have established panel of standard assays that are ready to be employed to measure product safety, identity, purity, stability, and potency. We have deep subject matter expertise and equipment to support a variety of analytical platforms including but not limited to, cell-based assays using flow cytometry readouts, immunoassays, protein-based assays, molecular biology techniques like PCR and NGS-based methods, biophysical methods, and microbiology.

Product QC Release Testing

Product QC Release Testing

BaseCamp® offers more than 40 state-of-the-art quality control release methods in-house to support in process control and cGMP product release. We offer seamless assay qualifications and transfers with aligned equipment and protocols between Analytical Development and Quality Control. Quality Control has separate labs for cell therapy and viral vector workstreams. Together, we can accelerate the release of your programs for clinical development and commercialization.

Stability

Stability

BaseCamp offers stability study programs for your products in accordance with ICH guidelines. We will develop customized stability study protocols with you based on your program needs and perform studies at various storage temperature and timepoints.

Quality Assurance and Validation

Quality Assurance and Validation

Our Quality assurance team provides oversight to our entire cGMP operation and ensures cGMP compliance are maintained through our established quality systems. Our systems, analytics and QC labs with state-of-the-art automation enable us to assure proper quality and prepare your products, faster.

BaseCamp’s development of platform analytics supports a range of release testing for cell and gene therapy products using LentiPeakTM, our proprietary lentiviral vector (LVV) platform.

Analytical Development and Quality Control work collaboratively to offer a complete analytical control strategy for partners using our LentiPeak™ platform. Most assays are tested on site to reduce costs and improve turnaround times.

Explore LentiPeak™

Our Technology Platforms

We gain insights across gene editing, cell therapy, and RNA, protein, and vector technologies to create a virtuous cycle that enable us to iterate and apply best practices across our ecosystem to accelerate and improve the product development process.

Learn about our technology

Our Therapeutic Approaches

Our expansive network of technologies and capabilities enables us to discover, develop, manufacture, and commercialize a broad spectrum of cell and gene therapies.

Learn about our therapeutic designs

What’s New

All News & Pubs

// May 12, 2025

ElevateBio Appoints Ger Brophy, Ph.D., as Interim Chief Executive Officer and Member of the Board of Directors

Read More about ElevateBio Appoints Ger Brophy, Ph.D., as Interim Chief Executive Officer and Member of the Board of Directors

// April 28, 2025

ElevateBio Announces Presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting

Read More about ElevateBio Announces Presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting

Elevated Insights

ElevateBio’s Next-Generation Sequencing Core: Meeting the Challenges of Cost, Time and Data Quality with Expertise and Collaboration

By Adriana Geldart, Ph.D., Senior Director, Next-Generation Sequencing, ElevateBio

View Insight

Partner with ElevateBio®

Wherever you are in your product lifecycle, we can strengthen and accelerate the development of your transformative therapies with our enabling technologies unmatched manufacturing capabilities.

Work with Us

// Work with us

Footer

ElevateBio

Investors & Media

LinkedIn Twitter

© 2025 ElevateBio. All Rights Reserved.

Privacy & Cookie Policy

  • End-to-End Capabilities
  • Technology Platforms
  • Therapeutic Design & Approaches
  • Partnering
  • About
  • Investors & Media
  • Careers
  • Contact
MENU
  • End-to-End Capabilities
    • End-to-End Capabilities Overview
    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Services and Quality
    • Next-Generation Sequencing
    • Apheresis
    • Enabling Services
  • Technology Platforms
    • Technology Platforms Overview
    • Gene Editing
    • Cell Therapy Enabling Technologies
    • RNA, Protein & Vector Engineering
  • Therapeutic Design & Approaches
    • Therapeutic Design & Approaches Overview
    • Ex Vivo Cell & Gene Therapies
    • In Vivo Gene Therapies
  • Partnering
    • Partnering Overview
    • Industry Partnerships
    • Academic Partnerships
  • About
    • About Overview
    • Our Story
    • Our Ecosystem
    • Our Team
    • Culture of Expedition
    • Careers
  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Posters & Publications
    • Elevated Insights
  • Careers
  • Locations
  • Contact